IFRS 2 Share-based Payment: Preparing your ESOP for audit in Singapore

For most growth-stage Singapore startups, ESOPs are increasingly common as a retention and compensation tool, and the consequences of getting it wrong typically surface at the worst possible times: fundraise, M&A, IPO, or tax audit.

Audit season becomes a scramble when equity data lives across three spreadsheet versions, board approvals are buried in email threads, and vesting schedules don’t reconcile to the accounting system. When you lack documented valuation methodology, employees face unexpected tax spreads, and you risk inaccurate financial statements that can cost tens of thousands and delay fundraising.

According to Carta’s 2025 Startup Equity & Workforce Report, ESOP pools across APAC and Middle East (ME) represent 11–13% of fully diluted equity at later funding stages—which means the documentation burden is real and growing. Knowing what auditors are looking for, and building the infrastructure before they ask, is what separates a clean audit from a painful one.

ESOP is more than an HR exercise

ESOPs have always looked like issuing grants, updating cap tables, and employees checking their equity. The financial compliance layer either gets deferred or delegated to advisors who may not have full visibility into the underlying data. 

Your fundraising rounds, M&A, and IPOs require clean audited financials and defensible fair market valuation for every grant date going back years. In each of these situations, the cost of addressing the problem retroactively is significantly higher than building the process correctly from the start.

Retroactive valuations require reconstruction financials, market comparables, and cap table structures as they stood at each historical grant date. This process typically costs two to three times the price of maintaining current valuations, and one that may not be accepted by auditors or Inland Revenue Authority of Singapore (IRAS) if historical records are incomplete.

If you need a step-by-step implementation guide, and practical tools to help you craft an ESOP that works for your startup, check out Carta’s ESOP playbook.

→ Download our ESOP Playbook

Skipping a fair market valuation

Without a defensible fair market valuation (FMV) at each grant date, the entire ESOP program lacks financial foundation. Every downstream calculation such as expense recognition, tax treatment, and employee spread, depends on a number that does not exist.

The most immediate consequence is that you cannot justify the exercise price to auditors, investors, or IRAS. More significantly, employees cannot accurately calculate their taxable spread. Under Singapore’s deemed exercise rule, options are treated as exercised at vesting for foreign employees, triggering taxable income on the spread between exercise price and FMV at that date. If FMV was never properly determined, employees may file incorrect tax returns, exposing them personally to back-taxes, penalties, and interest.

When companies expand to jurisdictions with stricter requirements (US 409A, UK HMRC EMI, Australia ESS rules), historic grants with no FMV support become an immediate legal and tax liability.

Expensing share-based compensation

Under IFRS 2, share-based compensation (SBC) must be recognized over the vesting period. Companies that don’t recognize it are reporting higher profit than they actually have. When the error is eventually identified (typically by a Big Four auditor, a new CFO, or an investor’s diligence team), it can arrive as a single large charge in one period, materially impacting EBITDA and requiring prior-period restatements. A material EBITDA impact in one quarter, combined with prior-period restatements, can delay fundraising rounds, renegotiate deal terms, or complicate IPO filings.

Properly expensed SBC can also generate a legitimate corporate tax deduction on exercise in many jurisdictions. Companies that are not expensing that correctly may be leaving a legitimate tax benefit on the table.

The SBC expense calculation starts with the grant-date FMV, typically applied through a Black-Scholes model. Without a defensible FMV, the entire expense line is unverifiable. Auditors cannot sign off on a number with no documentary basis, which is why valuable and expense are inseparable.

The compounding risk

The consequences of deferring ESOP compliance as the company scales.

Three things that make your ESOP data defensible

Auditors move quickly through audit procedures when ESOP data is defensible. When it’s not, you get follow-up questions, data requests, and delays in close.

1. Valuation methodology

Your valuation must be consistent, documented, and board-approved. In practice, this means:

• Pick a methodology and stick with it. Most startups use market comparable (recent funding round or comparable multiples) or income approach (discounted cash flow). Be sure to document your assumptions such as revenue growth, EBITDA margin, discount rate, probability of exit, and time to exit.

• Get board approval. The board should formally approve the valuation methodology at least once per year. If methodology changes, document why.

• Refresh when material events occur. Refresh your valuation after new funding rounds, M&A, or material business changes. 

• Know Singapore-specific rules. IRAS guidance defines fair value for ESOP purposes. The deemed exercise rule interacts with your valuation, so make sure to align your accounting and tax treatment with a tax advisor.

2. Expense calculation tied to cap table data

Share-based payment expense is defensible only if it flows from accurate cap table data.

Here’s an example: You grant 100,000 options on January 1 at $0.10 per share ($10,000 total). Under IFRS 2, that $10,000 is recognized over four-year vesting, which means $2,500 per year or $208 per month. Your accounting system calculates this based on vesting progress.

Carta data shows that the four-year grant with one-year cliff followed by monthly vesting is the most common award structure across APAC and ME—so auditors will expect documentation to reflect this clearly.

This is where data typically breaks down: The cap table records 100,000 options, but accounting shows 95,000 because mid-year forfeitures were not updated, or the grant dates in the two systems don’t match. When auditors reconcile your cap table to expense, these gaps become obvious and require investigation.

Here’s what defensible looks like:

• Grants must be recorded on the same effective date in both systems

• Forfeitures, cancellations, and exercises should be tracked consistently across both

• At period end, you should be able to produce a clean reconciliation—opening balance, grants issued, forfeitures, exercises, closing balance—with expense directly tied to that activity

3. Approval trails and documentation

Auditors check whether equity decisions were made through a proper process, with documented evidence. Most startups get caught off guard here because the records often exist, but are not organized or retrievable on demand.

• Board minutes and resolutions: The equity plan itself, and each material amendment to it, should be formally approved by the board with a documented resolution

• Grant agreements and offer letters: Every grant should have a signed grant agreement on file

• Exercise notices : When employees exercise options, the exercise notice and the corresponding equity record should be filed together, creating a clear trail from grant to exercise to ownership.

• Clear records: Employee vesting, forfeitures, and cancellations should be recorded typically in a vesting schedule maintained by HR or finance.

The practical test: If an auditor asked you to produce the signed grant agreement for a specific option issued three years ago, how long would it take? If the answer is hours or days, your approval trail infrastructure needs work before your next audit cycle.

How Carta helps APAC startups stay audit-ready

When equity data lives across disconnected systems, every auditor question requires hunting across spreadsheets and email chains. Carta helps startups across APAC—including Singapore, Australia, and Hong Kong—centralize that infrastructure so audit readiness becomes routine rather than reactive:

• Centralized grant management: Issue, track, and manage all option grants in one system—with grant dates, exercise prices, vesting schedules, and forfeiture records that stay reconciled to your accounting records

• Audit-ready documentation: Valuation reports and equity transaction records that withstand rigorous diligence without friction

• ESOP expense reporting and amortization: Automatically calculate ESOP expense recognition across vesting schedules, ensuring accurate amortization in your financial statements

• ESOP compliance and automation: Automate grant agreements, vesting schedules, and exercise mechanics, and generate fully documented equity plans

• Multi-entity support: Manage transfer pricing and offshore entity documentation in one platform, reducing complexity during investor review

For finance leads or CFOs, having your financial and equity house in order before an audit starts is the difference between moving fast and stalling. The best time to prepare is now.